CSat Investment Advisory’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$16K Sell
86
-3
-3% -$529 0.01% 406
2020
Q4
$15K Sell
89
-979
-92% -$143K 0.01% 391
2020
Q3
$133K Buy
1,068
+29
+3% +$3.59K 0.01% 365
2020
Q2
$101K Buy
1,039
+207
+25% +$21.5K 0.01% 466
2020
Q1
$75K Buy
832
+89
+12% +$11.5K 0.02% 408
2019
Q4
$110K Buy
743
+107
+17% +$14.4K 0.03% 343
2019
Q3
$77K Buy
636
+58
+10% +$7.5K 0.02% 371
2019
Q2
$78K Buy
578
+509
+738% +$64.4K 0.03% 347
2019
Q1
$9K Buy
69
+10
+17% +$1.34K ﹤0.01% 444
2018
Q4
$7K Buy
59
+15
+34% +$2.01K ﹤0.01% 456
2018
Q3
$6K Sell
44
-12
-21% -$1.49K ﹤0.01% 447
2018
Q2
$6K Buy
+56
New +$5.67K ﹤0.01% 434

Other funds holding HCA

CSat Investment Advisory's HCA Position: Q1 2021 in Review

CSat Investment Advisory reduced its HCA Healthcare (HCA) stake by 3.4% in Q1 2021, selling an estimated $529 and leaving 86 shares worth $16K. The position accounts for 0.01% of the portfolio, ranked #406.

CSat Investment Advisory first reported a position in HCA in Q2 2018 and has held it in 12 quarters since. The position peaked at $133K in Q3 2020. 787 funds tracked by Wall St. Rank hold HCA as of Q1 2021.

  • CSat Investment Advisory held 86 shares of HCA Healthcare worth $16K as of Q1 2021.
  • CSat Investment Advisory sold 3 HCA Healthcare shares in Q1 2021, an estimated $529.
  • HCA Healthcare made up 0.01% of CSat Investment Advisory's portfolio in Q1 2021, its #406 holding.
  • CSat Investment Advisory first reported a position in HCA Healthcare in Q2 2018 and has held it in 12 quarters since.
  • CSat Investment Advisory's HCA Healthcare position peaked at $133K in Q3 2020.
  • 787 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2021.

Based on CSat Investment Advisory's 13F filing for Q1 2021, filed 13 May 2021.